Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study. (Record no. 23653314)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02105 a2200601 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516202958.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201603s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1865-8652 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/s12325-014-0111-2 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Kinugawa, Koichiro |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20160310 |
| 245 00 - TITLE STATEMENT | |
| Title | Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Advances in therapy |
| Date of publication, distribution, etc. | Apr 2014 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 426-39 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-Arrhythmia Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Atrial Fibrillation |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Atrial Flutter |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Digoxin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Monitoring |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heart Rate |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Morpholines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Severity of Illness Index |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Stroke Volume |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Urea |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ventricular Dysfunction, Left |
| General subdivision | complications |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nagai, Ryozo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Inoue, Hiroshi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Atarashi, Hirotsugu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Seino, Yoshihiko |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yamashita, Takeshi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shimizu, Wataru |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Aiba, Takeshi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kitakaze, Masafumi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sakamoto, Atsuhiro |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ikeda, Takanori |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Imai, Yasushi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Daimon, Takashi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fujino, Katsuhiro |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nagano, Tetsuji |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Okamura, Tatsuaki |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hori, Masatsugu |
| 773 0# - HOST ITEM ENTRY | |
| Title | Advances in therapy |
| Related parts | vol. 31 |
| -- | no. 4 |
| -- | p. 426-39 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/s12325-014-0111-2">https://doi.org/10.1007/s12325-014-0111-2</a> |
| Public note | Available from publisher's website |
No items available.